FDA Panel Recommends Approval of New Oxycodone Formulation
By Emily P. Walker, Washington Correspondent, MedPage Today An FDA advisory panel voted to recommend approval of a new formulation of oxycodone hydrochloride (OxyContin) that is more difficult to crush or dissolve, and which may deter drug abuse. By a 14-4 margin, with one abstention, the panel recommended that the FDA approve Purdue Pharma’s application … Read more